These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 17935289)
1. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression. Chang YT; Cheng CM; Su YZ; Lee WT; Hsu JS; Liu GC; Cheng TL; Wang YM Bioconjug Chem; 2007; 18(6):1716-27. PubMed ID: 17935289 [TBL] [Abstract][Full Text] [Related]
2. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679 [TBL] [Abstract][Full Text] [Related]
3. Unexpected aggregation of neutral, xylene-cored dinuclear GdIII chelates in aqueous solution. Costa J; Balogh E; Turcry V; Tripier R; Le Baccon M; Chuburu F; Handel H; Helm L; Tóth E; Merbach AE Chemistry; 2006 Sep; 12(26):6841-51. PubMed ID: 16770815 [TBL] [Abstract][Full Text] [Related]
4. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
5. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related]
6. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics. Burai L; Tóth E; Sour A; Merbach AE Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439 [TBL] [Abstract][Full Text] [Related]
7. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging. Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474 [TBL] [Abstract][Full Text] [Related]
8. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling. Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity. Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and physicochemical characterization of carbon backbone modified [Gd(TTDA)(H2O)]2- derivatives. Chang YH; Chen CY; Singh G; Chen HY; Liu GC; Goan YG; Aime S; Wang YM Inorg Chem; 2011 Feb; 50(4):1275-87. PubMed ID: 21247114 [TBL] [Abstract][Full Text] [Related]
11. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, complexation and water exchange properties of Gd(III)-TTDA-mono and bis(amide) derivatives and their binding affinity to human serum albumin. Ou MH; Chen YM; Chang YH; Lu WK; Liu GC; Wang YM Dalton Trans; 2007 Jul; (26):2749-59. PubMed ID: 17592591 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of the novel monoamide derivatives of Gd-TTDA. Wang YM; Li CR; Huang YC; Ou MH; Liu GC Inorg Chem; 2005 Jan; 44(2):382-92. PubMed ID: 15651885 [TBL] [Abstract][Full Text] [Related]
14. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent. Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033 [TBL] [Abstract][Full Text] [Related]
15. Fine-tuning water exchange on Gd(III) poly(amino carboxylates) by modulation of steric crowding. Jászberényi Z; Sour A; Tóth E; Benmelouka M; Merbach AE Dalton Trans; 2005 Aug; (16):2713-9. PubMed ID: 16075110 [TBL] [Abstract][Full Text] [Related]
16. A novel cholic acid-based contrast enhancement agent for targeted MRI. Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094 [TBL] [Abstract][Full Text] [Related]
17. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5. Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715 [TBL] [Abstract][Full Text] [Related]
18. Target visualization by MRI using the avidin/biotin amplification route: synthesis and testing of a biotin-Gd-DOTA monoamide trimer. Tei L; Barge A; Geninatti Crich S; Pagliarin R; Negri V; Ramella D; Cravotto G; Aime S Chemistry; 2010 Jul; 16(27):8080-7. PubMed ID: 20533461 [TBL] [Abstract][Full Text] [Related]
19. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies. Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901 [TBL] [Abstract][Full Text] [Related]
20. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents. Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]